Rachel Ingraham

459 total citations
4 papers, 354 citations indexed

About

Rachel Ingraham is a scholar working on Molecular Biology, Neurology and Pathology and Forensic Medicine. According to data from OpenAlex, Rachel Ingraham has authored 4 papers receiving a total of 354 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Molecular Biology, 2 papers in Neurology and 1 paper in Pathology and Forensic Medicine. Recurrent topics in Rachel Ingraham's work include Neurofibromatosis and Schwannoma Cases (2 papers), Cancer Mechanisms and Therapy (1 paper) and Genomics, phytochemicals, and oxidative stress (1 paper). Rachel Ingraham is often cited by papers focused on Neurofibromatosis and Schwannoma Cases (2 papers), Cancer Mechanisms and Therapy (1 paper) and Genomics, phytochemicals, and oxidative stress (1 paper). Rachel Ingraham collaborates with scholars based in United States and Belgium. Rachel Ingraham's co-authors include Ophélia Maertens, Karen Cichowski, Clare F. Malone, Sandra Oršulić, Michael Santosuosso, Deyin Xing, Benjamin Forbes, Elda Righi, J. P. Yuan and Fabrizio Vianello and has published in prestigious journals such as Journal of Clinical Investigation, Cancer Research and Cancer Discovery.

In The Last Decade

Rachel Ingraham

4 papers receiving 351 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Rachel Ingraham United States	4	171	136	133	63	46	4	354
Renata Ferri Italy	10	148 0.9×	95 0.7×	127 1.0×	54 0.9×	39 0.8×	11	381
Batya Barkan Israel	7	77 0.5×	227 1.7×	268 2.0×	58 0.9×	27 0.6×	7	400
Quan-Sheng Zhu United States	9	148 0.9×	65 0.5×	234 1.8×	56 0.9×	94 2.0×	9	413
Sarah Gaffey United States	9	148 0.9×	71 0.5×	152 1.1×	33 0.5×	79 1.7×	22	402
Philip S. Hodkinson United Kingdom	7	258 1.5×	82 0.6×	202 1.5×	16 0.3×	50 1.1×	7	434
Tanya Smyczek Netherlands	6	110 0.6×	65 0.5×	265 2.0×	13 0.2×	17 0.4×	7	405
Xuemei Du China	6	288 1.7×	256 1.9×	149 1.1×	20 0.3×	49 1.1×	8	509
Amy Saur Conway United States	6	267 1.6×	173 1.3×	252 1.9×	23 0.4×	116 2.5×	8	584
Mansi Vasishtha United States	6	201 1.2×	92 0.7×	213 1.6×	26 0.4×	17 0.4×	6	517
Yumi Kinugasa Japan	9	254 1.5×	65 0.5×	273 2.1×	13 0.2×	56 1.2×	10	472

Countries citing papers authored by Rachel Ingraham

Since Specialization

Citations

This map shows the geographic impact of Rachel Ingraham's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rachel Ingraham with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rachel Ingraham more than expected).

Fields of papers citing papers by Rachel Ingraham

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rachel Ingraham. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rachel Ingraham. The network helps show where Rachel Ingraham may publish in the future.

Co-authorship network of co-authors of Rachel Ingraham

This figure shows the co-authorship network connecting the top 25 collaborators of Rachel Ingraham. A scholar is included among the top collaborators of Rachel Ingraham based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rachel Ingraham. Rachel Ingraham is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

4 of 4 papers shown

1.

Malone, Clare F., Rachel Ingraham, William Barbosa, et al.. (2017). mTOR and HDAC Inhibitors Converge on the TXNIP/Thioredoxin Pathway to Cause Catastrophic Oxidative Stress and Regression of RAS-Driven Tumors. Cancer Discovery. 7(12). 1450–1463. 87 indexed citations

2.

Lock, Rebecca, Rachel Ingraham, Ophélia Maertens, et al.. (2016). Cotargeting MNK and MEK kinases induces the regression of NF1-mutant cancers. Journal of Clinical Investigation. 126(6). 2181–2190. 22 indexed citations

3.

Malone, Clare F., Jody Fromm Longo, Ophélia Maertens, et al.. (2014). Defining Key Signaling Nodes and Therapeutic Biomarkers in NF1 -Mutant Cancers. Cancer Discovery. 4(9). 1062–1073. 54 indexed citations

4.

Righi, Elda, Satoshi Kashiwagi, J. P. Yuan, et al.. (2011). CXCL12/CXCR4 Blockade Induces Multimodal Antitumor Effects That Prolong Survival in an Immunocompetent Mouse Model of Ovarian Cancer. Cancer Research. 71(16). 5522–5534. 191 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact